The discrepancy, reported for the first time by Reuters, centres on the regimen administered to a smaller group of volunteers in the late-stage trials, of half a dose followed by a full dose. This diverged from the original plan of two full doses, given to the majority of participants.

The half-dose pattern was found to be 90% effective, versus the 62% success rate of the two-full-dose main study, based on interim data

Britain gets ready for roll-out of Pfizer’s COVID-19 vaccine this week

Dec 6, 2020

Some of the most famous figures in British life stepped forward to say that they would receive the vaccine to encourage the public to follow suit. That could include Queen Elizabeth II and her husband Prince Philip, who are likely to receive the vaccine within weeks, according to MailOnline reports on Sunday.

Even with vaccines, airport testing Is here for the long haul

Dec 5, 2020

There’s data to support the idea that testing could reestablish consumer confidence. In a study published by the Global Business Travel Association (GBTA) in October, 76% of respondents said that rapid testing prior to departure—with waived quarantining requirements for those who test negative—would be the best way to open up international travel.

Moscow rolls out Sputnik V COVID-19 vaccine to most exposed groups

Dec 5, 2020

Scientists have raised concerns about the speed at which Russia has worked, giving the regulatory go-ahead for its vaccines and launching mass vaccinations before full trials to test its safety and efficacy had been completed.

« Older Entries

Next Entries »

Briefs